```html

Gallbladder Fistula – Comprehensive Medical Guide

Overview

A gallbladder fistula is an abnormal connection (or “track”) that forms between the gallbladder and another organ or the abdominal cavity. The most common types are:

• Cholecysto‑enteric (gallbladder‑to‑intestine) fistulas, especially cholecysto‑duodenal.
• Cholecysto‑cutaneous (gallbladder‑to‑skin) fistulas.
• Cholecysto‑biliary (gallbladder‑to‑bile duct) fistulas.

These tracts usually develop as a complication of chronic gallstone disease, severe inflammation (cholecystitis) or gallbladder cancer. Gallbladder fistulas are relatively rare, accounting for 0.3–0.5% of all patients with gallstone disease according to the American Journal of Surgery. They most often affect adults over 50 years old, with a slight male predominance, and are more common in populations where gallstone disease is prevalent (e.g., Northwestern Europe, North America, and parts of Asia).

Symptoms

Because the fistula creates an abnormal passage for bile, symptoms can be subtle or dramatic. Common presentations include:

Digestive symptoms

• Abdominal pain: Usually in the right upper quadrant, may be intermittent or constant.
• Vomiting or nausea: Especially after fatty meals.
• Diarrhea or steatorrhea: Fatty, foul‑smelling stools due to bile entering the intestine directly.
• Upper‑mid abdominal fullness: A feeling of “bloat” after meals.

Specific signs of certain fistula types

• Biliary pneumobilia: Air in the biliary tree seen on imaging—typical of cholecysto‑enteric fistulas.
• External drainage: Yellow‑green pus or bile seeping through the skin in cholecysto‑cutaneous fistulas.
• Weight loss: Malabsorption from chronic diarrhea.

Systemic symptoms

• Fever and chills if infection (cholangitis, abscess) is present.
• Jaundice – yellowing of skin and eyes when bile flow to the intestine is obstructed.
• Generalized fatigue or malaise.

Because these symptoms overlap with other biliary conditions, a thorough evaluation is essential.

Causes and Risk Factors

Most gallbladder fistulas are acquired rather than congenital. The principal mechanisms are:

Chronic inflammation

• Recurrent acute cholecystitis or chronic cholecystitis leads to erosion of the gallbladder wall.
• Large, impacted gallstones can press against adjacent organs, causing pressure necrosis.

Gallbladder cancer

• Malignant invasion can breach the gallbladder wall, forming a fistulous tract.

Trauma or iatrogenic injury

• Abdominal surgery, percutaneous cholecystostomy tubes, or endoscopic procedures may unintentionally create a connection.

Infection

• Severe bacterial infection (e.g., *E. coli*, *Klebsiella*) can cause abscess formation and subsequent fistulization.

Risk Factors

• Age > 50 years.
• Male sex (slightly higher risk).
• Obesity – linked to higher gallstone prevalence.
• History of gallstones (especially > 2 cm), gallbladder polyps, or prior biliary surgery.
• Chronic liver disease or cirrhosis (altered bile composition).
• Diabetes mellitus – predisposes to infection and delayed healing.

Diagnosis

Because symptoms are nonspecific, imaging and laboratory studies are critical.

Laboratory tests

• Complete blood count (CBC) – may show leukocytosis if infection.
• Liver function tests (ALT, AST, ALP, GGT, bilirubin) – assess for obstructive jaundice.
• Serum amylase/lipase – to rule out pancreatitis.

Imaging studies

Ultrasound (US)

First‑line, bedside tool. May reveal gallstones, thickened gallbladder wall, or pneumobilia suggestive of a fistula.

Computed Tomography (CT) Scan

Contrast‑enhanced CT is the most sensitive modality. Classic findings include:

• Air in the biliary tree (pneumobilia).
• Direct visualization of a tract between the gallbladder and adjacent organ.
• Signs of inflammation or abscess.

Magnetic Resonance Cholangiopancreatography (MRCP)

Provides detailed images of biliary anatomy without ionizing radiation. Helpful for surgical planning.

Endoscopic Retrograde Cholangiopancreatography (ERCP)

Both diagnostic and therapeutic. Can identify a fistula, obtain brushings for cytology (if cancer suspected), and place stents to drain bile.

Upper Endoscopy (EGD) or Colonoscopy

May directly visualize an internal opening of a cholecysto‑enteric fistula, especially when the duodenum or colon is involved.

Diagnostic criteria (summary)

1. Clinical suspicion based on symptoms and risk factors.
2. Imaging evidence of a communicating tract or pneumobilia not explained by prior procedures.
3. Exclusion of alternative diagnoses (e.g., perforated ulcer, Crohn’s disease).

Treatment Options

Management depends on the patient’s overall health, fistula type, and presence of complications.

Conservative Management

• Observation: Small, asymptomatic fistulas may be watched, especially in high‑risk surgical candidates.
• Antibiotics: Broad‑spectrum coverage (e.g., ceftriaxone + metronidazole) for cholangitis or abscess.
• Nutritional support: Low‑fat diet, medium‑chain triglyceride (MCT) supplements to reduce bile flow.

Surgical Treatment

Definitive therapy for most patients.

Traditional Open Cholecystectomy with Fistula Repair

• Removal of the gallbladder and resection of the fistulous tract.
• Primary closure of the involved organ (e.g., duodenal repair) or segmental resection if needed.
• Indicated when the fistula is large, there is suspicion of cancer, or when minimally invasive options are contraindicated.

Laparoscopic Cholecystectomy

• Increasingly used for selected cases; advantages include less postoperative pain and quicker recovery.
• May require conversion to open surgery if dense adhesions are encountered.

Segmental Bowel Resection

• For cholecysto‑enteric fistulas involving a diseased segment of the intestine (e.g., duodenum, colon).

Endoscopic and Radiologic Options

• ERCP with biliary stenting: Diverts bile flow, allowing the fistula to close spontaneously in select patients.
• Percutaneous transhepatic biliary drainage (PTBD): Temporary external drainage for severe obstruction.

Medical Adjuncts

• Proton‑pump inhibitors (PPIs) if coexisting peptic ulcer disease.
• Analgesics (acetaminophen, low‑dose NSAIDs if no contraindication).
• Vitamin K or fat‑soluble vitamin supplementation if chronic malabsorption occurs.

Post‑operative care

• Monitor for bile leak, infection, and wound healing.
• Gradual re‑introduction of a low‑fat diet, advancing as tolerated.
• Follow‑up imaging (ultrasound or CT) 4–6 weeks after surgery to confirm fistula closure.

Living with Gallbladder Fistula

Even after successful treatment, patients may need ongoing adjustments.

Dietary tips

• Eat small, frequent meals low in saturated fat (≤ 30 g per day).
• Choose lean proteins, steamed vegetables, and whole grains.
• Avoid fried foods, high‑fat dairy, and large, greasy meals that trigger bile release.
• Consider MCT oil supplements if you have persistent diarrhea; they are absorbed directly into the portal system.

Hydration & Bowel Health

• Drink at least 2 L of water daily.
• Include soluble fiber (e.g., oats, apples) to bulk stools without exacerbating steatorrhea.

Medication adherence

• Complete any prescribed antibiotic courses.
• Take acid‑suppressive therapy if recommended.
• Report any new abdominal pain or changes in stool color immediately.

Physical activity

• Gentle walks 20–30 minutes most days are safe after recovery.
• Avoid heavy lifting (> 10 kg) for 4–6 weeks post‑surgery.

Follow‑up schedule

• First visit 2 weeks post‑op for wound check and labs.
• Imaging at 1–2 months to confirm fistula resolution.
• Annual physicals thereafter, with liver function tests if there is a history of cholestasis.

Prevention

Because most fistulas stem from gallstone disease, primary prevention focuses on reducing gallstone formation and managing inflammation.

• Maintain a healthy weight: BMI < 25 kg/m² reduces gallstone risk (CDC data).
• Balanced diet: High‑fiber, low‑refined‑carb meals; limit rapid weight‑loss diets that can precipitate gallstones.
• Regular physical activity: ≥ 150 minutes of moderate aerobic exercise per week (WHO recommendation).
• Control diabetes and lipid levels: Statins may lower cholesterol saturation in bile.
• Avoid prolonged fasting: When fasting is unavoidable (e.g., pre‑surgery), consider short‑term ursodeoxycholic acid under physician guidance.
• Prompt treatment of acute cholecystitis: Early antibiotics and, when indicated, timely cholecystectomy (< 72 h) reduces progression to fistula.

Complications

If a gallbladder fistula is left untreated, several serious problems can arise:

• Ascending cholangitis: Infection of the biliary tree—can be life‑threatening.
• Biliary peritonitis: Leakage of bile into the abdominal cavity causing severe inflammation.
• Intestinal obstruction: Large fistulas can act as a “lead point” for gallstone ileus, a mechanical blockage most often in the terminal ileum.
• Malabsorption & Nutritional deficiencies: Chronic diarrhea leads to loss of fat‑soluble vitamins (A, D, E, K).
• Sepsis: Bacterial overgrowth within the fistulous tract may spread systemically.
• Gallbladder carcinoma: Persistent inflammation increases long‑term cancer risk; surveillance is advised in chronic cases.

When to Seek Emergency Care

References

• Mayo Clinic. “Gallbladder disease.” https://www.mayoclinic.org
• American College of Surgeons. “Gallstone Ileus and Biliary Fistula.” https://www.facs.org
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Gallstones.” https://www.niddk.nih.gov
• World Health Organization. “Obesity and Overweight.” https://www.who.int
• Centers for Disease Control and Prevention. “Gallbladder disease risk factors.” https://www.cdc.gov
• Jiang, Y. et al. “Incidence and Management of Cholecystoenteric Fistulas.” *American Journal of Surgery*, 2021; 222(4): 676‑682. DOI:10.1016/j.amjsurg.2021.01.018

```